Your browser doesn't support javascript.
loading
Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease.
Martin de Miguel, Irene; Kamath, Patrick S; Egbe, Alexander C; Jain, C Charles; Cetta, Frank; Connolly, Heidi M; Miranda, William R.
Afiliación
  • Martin de Miguel I; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kamath PS; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Egbe AC; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Jain CC; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Cetta F; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Connolly HM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Miranda WR; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA miranda.william@mayo.edu.
Heart ; 109(8): 619-625, 2023 03 27.
Article en En | MEDLINE | ID: mdl-36581444
OBJECTIVES: Fontan-associated liver disease (FALD) is universal post-Fontan palliation; however, its impact on survival remains controversial and current diagnostic tools have limitations. We aimed to assess the prognostic role of liver fibrosis scores (aminotransferase to platelet ratio [APRI] and fibrosis-4 [FIB-4]) and their association with haemodynamics and other markers of liver disease. METHODS: 159 adults (age ≥18 years) post-Fontan undergoing catheterisation at Mayo Clinic, Minnesota, between 1999 and 2017 were included. Invasive haemodynamics and FALD-related laboratory, imaging and pathology data were documented. RESULTS: Mean age was 31.5±9.3 years, while median age at Fontan procedure was 7.5 years (4-14). Median APRI score (n=159) was 0.49 (0.33-0.61) and median FIB-4 score (n=94) was 1.12 (0.71-1.65). Correlations between APRI and FIB-4 scores and Fontan pressures (r=0.30, p=0.0002; r=0.34, p=0.0008, respectively) and pulmonary arterial wedge pressure (r=0.25, p=0.002; r=0.30, p=0.005, respectively) were weak. Median average hepatic stiffness by magnetic resonance elastography was 4.9 kPa (4.3-6.0; n=26) and 24 (77.4%) showed stage 3 or 4 liver fibrosis on biopsy; these variables were not associated with APRI/FIB-4 scores. On multivariable analyses, APRI and FIB-4 scores were independently associated with overall mortality (HR 1.31 [1.07-1.55] per unit increase, p=0.003; HR 2.15 [1.31-3.54] per unit increase, p=0.003, respectively). CONCLUSIONS: APRI and FIB-4 scores were associated with long-term all-cause mortality in Fontan patients independent of other prognostic markers. Correlations between haemodynamic status and liver scores were weak; furthermore, most markers of liver fibrosis failed to correlate with non-invasive indices, underscoring the complexity of FALD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido